Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.

MLA

Jiang, Hua, et al. “Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III.” The Journal of Biological Chemistry, vol. 286, no. 7, Feb. 2011, pp. 5913–20. EBSCOhost, https://doi.org/10.1074/jbc.M110.192252.

APA

Jiang, H., Wang, H., Tan, Z., Hu, S., Wang, H., Shi, B., Yang, L., Li, P., Gu, J., Wang, H., & Li, Z. (2011). Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III. The Journal of Biological Chemistry, 286(7), 5913–5920. https://doi.org/10.1074/jbc.M110.192252

Chicago

Jiang, Hua, Huamao Wang, Zhonghua Tan, Suwen Hu, Hai Wang, Bizhi Shi, Lin Yang, et al. 2011. “Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III.” The Journal of Biological Chemistry 286 (7): 5913–20. doi:10.1074/jbc.M110.192252.